Molecular Genomic Testing for Breast Cancer: Utility for Surgeons.


Journal Article (Review)

Molecular genomic testing provides clinicians with both prognostic and (sometimes) predictive information that can help individualize treatment and decrease the risk of over- or under-treatment. We review the genomic tests that are currently available for clinical use in management of breast cancer, discuss ongoing research related to validating and expanding their utility in different patient populations, and explain why it is important for surgeons to know how to incorporate these tools into their clinical practice in order to individualize patient treatment, reduce unnecessary morbidity, and, accordingly, improve outcomes.

Full Text

Duke Authors

Cited Authors

  • Fayanju, OM; Park, KU; Lucci, A

Published Date

  • February 2018

Published In

Volume / Issue

  • 25 / 2

Start / End Page

  • 512 - 519

PubMed ID

  • 29159748

Pubmed Central ID

  • 29159748

Electronic International Standard Serial Number (EISSN)

  • 1534-4681

Digital Object Identifier (DOI)

  • 10.1245/s10434-017-6254-z


  • eng

Conference Location

  • United States